Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.
Saved in:
| Title: | Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality. |
|---|---|
| Authors: | Cirulli GO; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Davis M; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Stephens A; Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA., Chiarelli G; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy., Finati M; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy., Chase M; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Tinsley S; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Arora S; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Sood A; Department of Urology, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio, US., Lughezzani G; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy., Buffi N; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy., Carrieri G; Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy., Salonia A; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Briganti A; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Montorsi F; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Rogers C; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Abdollah F; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA. |
| Source: | Cancer [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35563. Date of Electronic Publication: 2024 Oct 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
